Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.
Biobeat has raised $50.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.
Biobeat's investors include OrbiMed, Ally Bridge Group, Elevage Medical Technologies, Menomadin Foundation.
Biobeat is headquartered in Boca Raton, United States.
Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.
Biobeat is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biobeat — Funding & Investors." VCBacked, December 30, 2025, https://www.vcbacked.co/company/biobeat. Accessed July 30, 2026.
VCBacked. (2025). Biobeat — Funding & Investors. Retrieved July 30, 2026, from https://www.vcbacked.co/company/biobeat
{{cite web |title=Biobeat — Funding & Investors |url=https://www.vcbacked.co/company/biobeat |website=VCBacked |access-date=July 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated